Efficacy and Safety of Tegoprazan-Containing Versus Proton Pump Inhibitor-Containing Regimens for First Line Helicobacter pylori Eradication-An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Gao Y, Xing JH, Fu MM, Zhao J, Li WY, Yang FK

Open source

DOI
10.1111/hel.70167
Published
2026 Nov-Dec
Container
Helicobacter
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/hel.70167,
  title = {Efficacy and Safety of Tegoprazan-Containing Versus Proton Pump Inhibitor-Containing Regimens for First Line Helicobacter pylori Eradication-An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.},
  author = {Gao Y and Xing JH and Fu MM and Zhao J and Li WY and Yang FK},
  year = {2026},
  journal = {Helicobacter},
  doi = {10.1111/hel.70167},
  url = {https://doi.org/10.1111/hel.70167}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Tegoprazan-Containing Versus Proton Pump Inhibitor-Containing Regimens for First Line Helicobacter pylori Eradication-An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
AU  - Gao Y
AU  - Xing JH
AU  - Fu MM
AU  - Zhao J
AU  - Li WY
AU  - Yang FK
PY  - 2026
JO  - Helicobacter
DO  - 10.1111/hel.70167
UR  - https://doi.org/10.1111/hel.70167
ER  - 

APA

Y, G., JH, X., MM, F., J, Z., WY, L., & FK, Y. (2026). Efficacy and Safety of Tegoprazan-Containing Versus Proton Pump Inhibitor-Containing Regimens for First Line Helicobacter pylori Eradication-An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Helicobacter. https://doi.org/10.1111/hel.70167

Source records